CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases

Clinical trial NCT06941129 · RECRUITING

Trial details

NCT number: NCT06941129
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Systemic Sclerosis (SSc)Inflammatory Myopathy ANCA-Associated Vasculitis (AAV)Connective Tissue Disease-Associated Thrombocytopenia SLE-ITP

Start date: 2025-02-11
Primary completion: 2028-02-18
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.